Scientists hunt for better breast cancer blood tests
NCT ID NCT05054010
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing commercially available antibodies to see if they can identify breast cancer markers in blood samples. Researchers will collect blood from 84 people, including breast cancer patients and healthy volunteers. The goal is to improve detection of circulating tumor cells, which could help with diagnosis or monitoring in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better blood tests for detecting breast cancer cells, potentially improving early diagnosis or monitoring.
- What could go wrong
- This is an early exploratory study with only 84 participants, so results may not apply broadly. The antibodies are for research use only, not yet for clinical diagnosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ospedale San Raffaele
Milan, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smartwatch could spot nerve damage before it starts
- Can acupuncture soothe the mind and body in breast cancer?
- CT scans may predict breast reconstruction flap failure
- A gentle jog might be the key to better sleep for breast cancer survivors
- Can a Two-Drug attack shrink Hard-to-Treat breast cancer?
- Can mapping tumor DNA unlock personalized breast cancer care?